- Kanters A, Vu J, Schuman A, Van Wieren I, Duby A, Hardiman K, Hendren S: Completeness of operative reports for rectal cancer surgery. American Journal of Surgery. In Press.
- Hendren S, Vu J, Suwanabol P, Kamdar N, Hardiman, KM: Hospital variation in readmissions and visits to the emergency department following ileostomy surgery: a population-based cohort study. J of Gastrointestinal Surgery. In Press.
- De Roo AC, Morris AM, Vu JV, Schuman A, Abbott K, Kandagatla P, Hardiman KM, Hendren S: Characteristics of Patients Seeking Second Opinions at a Multidisciplinary Colorectal Cancer Clinic. Dis Colon Rectum. In Press.
- Frydrych L, Ulintz P, Bankhead A, Sifuentes C, Greenson J, Maguire L, Irwin R, Fearon ER, Hardiman KM: Rectal Cancer Sub-Clones Respond Differentially to Neoadjuvant Therapy. Neoplasia. In press.
- Maguire L, Geiger T, Hardiman KM, Regenbogen SE, Hopkins B, Muldoon R, Hawkins A: Surgical Management of Primary Lymphoma: Big Data for a Rare Problem, J of Surgical Oncology. J Surg Oncol. 2019 Jun 11. doi: 10.1002/jso.25582. [Epub ahead of print]. PM31187517
- Hardiman KM, Antunez AG, Kanters A, Schuman AD, Regenbogen SE: Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer Journal of Surgical Oncology. 2019 Apr 16. doi: 10.1002/jso.25474. PM30993710
- Vu JV, Matusko N, Hendren S, Regenbogen SE, Hardiman KM: Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent. Dis Colon Rectum doi: 10.1097/DCR. 000000000000132, 2019. PM30640317
- Kandagatla P, Nikolian VC, Matsuoka N, Mason S, Regenbogen SE, Hardiman KM: Assessment of patient-reported outcomes and readmission after ileostomy creation in older adults. American Surgeon 84 (11): 1814-1818, 2018.
- Kandagatla P, Maguire LH, Hardiman KM: Biology of Nodal Spread in Colon Cancer: Insights from Molecular and Genetic Studies. Eur Surg Res 59(5-6): 361-370, 2018. PM30537705
- Vu JV, De Roo A, Hardiman KM: Can ZEB2 Be Used as a Molecular Marker for Risk Stratification of Patients With Colorectal Cancer? JAMA Netw Open 1(6): e183133, 2018. PM30646215
- Hardiman KM: Translational Research in Colorectal Cancer. Clin Colon Rectal Surg 31(3): 145-146, 2018. PM29720899/PMC5930113
- Suwanabol PA, Hardiman KM: Prevention and Management of Colostomy Complications: Retraction and Stenosis. Dis Colon Rectum 61(12): 1344-1347, 2018. PM30399047
- Hardiman KM: Update on Sporadic Colorectal Cancer Genetics. Clin Colon Rectal Surg 31(3): 147-152, 2018. PM29720900
- Ulintz PJ, Greenson JK, Wu R, Fearon ER, Hardiman KM: Lymph Node Metastases in Colon Cancer are Polyclonal Clin Cancer Res online: doi: 10.1158/1078-0432, 2017. PM29203589
- Dosch J, Ziemke E, Wan S, Luker K, Welling T, Hardiman K, Fearon E, Thomas S, Flynn M, Rios-Doria J, Hollingsworth R, Herbst R, Hurt E, Sebolt-Leopold J: Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget 8(39): 65090-65099, 2017. PM29029414/PMC5630314
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2024 The University of Alabama at Birmingham
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.